25-085-NCP: SIGNAL-ER 101: Signatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer
- Title
- SIGNAL-ER 101: Signatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer
- Principal Investigator
- Jiang, Bei
- Phase
- II
- Age Group
- Adult
- Applicable Disease Sites
- Breast Cancer
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Kaitlyn Hager
- Research Nurse
- Email: kaitlyn.hager@hsc.wvu.edu